Sodium chloride solution for drug reconstitution or dilution

Details for Australian Patent Application No. 2006308921 (hide)

Owner Wyeth

Inventors Zerfas, Julie; Webb, Chandra A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006308921

PCT Pub. Number WO2007/053533

Priority 60/732,221 01.11.05 US

Filing date 27 October 2006

Wipo publication date 10 May 2007

Acceptance publication date 19 July 2012

International Classifications

A61K 9/08 Medicinal preparations characterised by special physical form - Solutions

A61K 38/48 Medicinal preparations containing peptides

A61K 47/02 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/18 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/053533 Priority application(s): WO2007/053533

19 July 2012 Application Accepted

  Published as AU-B-2006308921

4 October 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 23 Aug 2012 . Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006308946-Vancomycin formulations having reduced amount of histamine

2006308914-Compositions and methods for identifying modulators of TRPV2